GlassScriptPhysician profile
Gannon Marsh
NPI 1356706907
$261.88
in general payments reported to CMS, 2019-2025
8 companies · $27.08 in 2025
The $27.08 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.54 · 2022: $40.61 · 2023: $155 · 2025: $27.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $116.35 | 2022-2023 | Blastx, Xperience, Surgx |
| Urgo Medical North America, LLC | $41.32 | 2023-2025 | Urgoclean Ag, Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Smith+Nephew, INC. | $29.60 | 2023 | Regranex, Collagenase Santyl, Grafix |
| Tactile Systems Technology INC | $21.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.41 | 2021 | |
| Kci USA, INC. | $13.10 | 2023 | 3m Cavilon, V.A.C. Dermatac, Activ.A.C. |
| Amgen INC. | $12.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gannon Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.